Clover Health (NASDAQ: CLOV) isn't a garden-variety health insurance company, because most people in the U.S. aren't eligible to subscribe to its service. Clover administrates Medicare Advantage insurance programs, which are backed by the U.S. government and purchasable by eligible Medicare recipients looking for broader coverage.
In such a tightly regulated industry that's packed with powerful competitors, Clover Health has a lot to prove as the new player on the scene. But, with its information technology-heavy approach to providing care and an increasing level of buy-in from key stakeholders like physicians and patients, it just might have what it takes. Let's explore what's good and what's not so good about this company to see if its stock might be a worthwhile purchase.
Image source: Getty Images.
Source Fool.com